Max’s ISP seminar

Today, Max Sannemalm – now a PhD student 🎉 – held his individual study plan (ISP) seminar. The ISP seminar is an opportunity to get input and feedback before starting the projects. Marianne Kristiansson and Joar Guterstam participated from the advisory board and Nitya Jayaram-Lindström participated as an adjunct member.

At the seminar, Max presented the four studies which forms his doctoral studies:

He will be conducting the B4DT study, a non-inferiority study comparing the Bergen 4-day treatment for OCD to conventional CBT for OCD. Along with the RCT, he will do a cost-effectiveness analysis and a qualitative analysis about B4DT and its implementation. In addition, the plan is to do a pilot trial of an ultra-intensive treatment for patients with body dysmorphic disorder (BDD).

Looking forward to seeing Max working wonders!

Introducing Max Sannemalm and the Bergen 4-Day Treatment for OCD

Sunny midsummer was great, but we are even happier that Max Sannemalm just joined our group!

Max is a licensed psychologist and will be joining us as the project coordinator for the randomized controlled non-inferiority trial study comparing the Bergen 4-Day Treatment (B4DT) to gold-standard CBT for OCD.

The Bergen 4-Day Treatment (B4DT) is a new concentrated treatment for OCD developed by Gerd Kvale and Bjarne Hansen from Bergen. In B4DT, patients receive ERP at a clinic during 4 consecutive days. The B4DT has shown to achieve remission in around 70% of patients when delivered in regular care in several uncontrolled treatment trials, and one randomized controlled trial (RCT) including a self-help group and a waitlist group. However, it has yet to be directly compared to gold-standard CBT.

The study will test the non-inferiority, speed of recovery, and cost-effectiveness of B4DT, compared to gold-standard.

To summarize: Exciting things ahead, and welcome to the group, Max!